Citi Pharma submits offer for pharma company acquisition
Wire desk byline Sourced from Xinhua, Dawn, Arab News, Anadolu and Minute Mirror. Translated and abridged by the GSRRA Desk.
Citi Pharma Limited (PSX: CPHL) has submitted a Non-Binding Offer for the potential acquisition of a leading pharmaceuticals company in Pakistan.
The submission is part of the company’s ongoing strategic expansion plans to become one of the largest players in the pharma industry of Pakistan.
Any further developments will be subject to the outcome of the due diligence process and subsequent approval(s) by the Board of Directors and relevant regulatory authorities.
The aforementioned information was disseminated through a notification to Exchange.
The Company remains committed to keeping the Exchange and shareholders informed of any material developments in this regard.
Reference Link:- https://mettisglobal.news/citi-pharma-submits-offer-for-pharma-company-acquisition/
Zamir Ahmed Awan is the founder and Chair of the Global Silk Route Research Alliance, a think tank in Islamabad. He studied engineering at Shanghai University in the 1980s, and years later he went back to China as Pakistan's science counsellor in Beijing, from 2010 until 2016, working on science and higher education cooperation between the two countries.…
